TRML NASDAQ
Tourmaline Bio, Inc.
1W: +0.0%
1M: +0.2%
3M: +120.5%
1Y: +74.8%
3Y: +574.8%
$47.98
Last traded 2025-10-30 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$39K
-18.2% ▼
Operating Income
-$90M
-97.6% ▼
Net Income
-$73M
-73.8% ▼
EPS (Diluted)
$-2.89
+67.4% ▲
EBITDA
-$90M
-97.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $447K | $623K | $6K | $33K | $39K |
| Gross Profit | -$447K | -$623K | -$6K | -$33K | -$39K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $15M | $212 | $18M | $32M | $67M |
| SG&A Expenses | $7M | $692 | $2M | $13M | $23M |
| Operating Expenses | $22M | $47M | $20M | $45M | $90M |
| Operating Income | -$23M | -$48M | -$20M | -$45M | -$90M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $23K | $326K | $0 | $0 | $0 |
| Income Before Tax | -$23M | -$48M | -$20M | -$42M | -$73M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$23M | -$904 | -$20M | -$42M | -$73M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-33.97 | $-0.00 | $-0.97 | $-8.87 | $-2.89 |
| EBITDA | -$22M | -$47M | -$20M | -$42M | -$90M |
| Shares Outstanding | 668506 | 11M | 20M | 5M | 25M |